Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Multicentre Therapeutic Confirmatory Study to Evaluate the Efficacy and Safety of Proxinium Plus Best Supportive Care Versus Best Supportive Care Alone in Patients With Advanced SCCHN Who Have Received at Least One Anti-cancer Treatment Regimen for Advanced Disease

NCT00412776 is registered in ClinicalTrials.gov with Sesen Bio, Inc. as lead sponsor.

NCT NCT00412776
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00412776 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Multicentre Therapeutic Confirmatory Study to Evaluate the Efficacy and Safety of Proxinium Plus Best Supportive Care Versus Best Supportive Care Alone in Patients With Advanced SCCHN Who Have Received at Least One Anti-cancer Treatment Regimen for Advanced Disease
Lead sponsor
Sesen Bio, Inc.
Phase
Phase 2/3
Overall status
Terminated
Start date
December 31, 2005
Completion date
April 30, 2008
Enrollment
165 (actual)
Sites
122

Conditions

As the registry lists them; a condition with its own page is linked.

carcinoma, squamous cell, carcinoma, squamous cell of head and neck, head and neck cancer, head and neck neoplasms, mouth neoplasms, neoplasms, squamous cell